• Zika Vaccines Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Zika Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Zika Vaccines Market, By Regions
• Zika Vaccines Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Zika Vaccines Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Zika Vaccines Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Zika Vaccines Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Continuous increase in human clinical trials and rise in number of zika cases will drive the
growth of Zika vaccines market
As of March 2016, 67 companies and research institutions were working on various kinds of
R&D projects and clinical trials aided to develop effective vaccines against zika virus. The FDA
approved the first human clinical trial for GLS–5700 in June 2016, a zika vaccine being
developed by Inovio Pharmaceuticals. Further in 2017, a grant was approved for phase 2
clinical trials for a DNA vaccine conducted by NIAID’s Vaccine Research Center (VRC).
Increasing awareness among the population would aid in controlling the incidence rate of zika
infection. The WHO implemented a global framework for creating public awareness through its
Zika Strategic Response Framework and Joint Plan in February 2016. This plan outlines all the
points to be taken care of at the time of infections. In June 2016, WHO Regional Office for
Europe developed a training curriculum to increase awareness by the publication of Zika Risk
Assessment for European Region.